These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5894765)

  • 1. Phenylketonuria; the patogenetic problems of a molecular disease affecting the nervous system.
    Knox WE
    Shinkei Kenkyu No Shimpo; 1965 Sep; 9(3):510-2. PubMed ID: 5894765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phenylketonuria (phenylalanine hydroxylase deficiency)].
    Owada M
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):114-8. PubMed ID: 9590003
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenylketonuria.
    Med Lett Drugs Ther; 1969 May; 11(9):39-40. PubMed ID: 5795985
    [No Abstract]   [Full Text] [Related]  

  • 4. [Genetical heterogeneity of phenylketonuria].
    Annenkov GA
    Vopr Med Khim; 1982; 28(3):62-70. PubMed ID: 7048735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria.
    Infante JP; Huszagh VA
    Mol Genet Metab; 2001 Mar; 72(3):185-98. PubMed ID: 11243724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the brain barrier system function and changes of cerebrospinal fluid concentrations of phenylalanine and tyrosine in human phenylketonuria.
    Ratzmann GW; Grimm U; Jährig K; Knapp A
    Biomed Biochim Acta; 1984; 43(2):197-204. PubMed ID: 6732755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenetic aspects of some congenital errors of metabolism].
    CUTILLO S
    Pediatria (Napoli); 1962; 70():x-xvi contd. PubMed ID: 13882811
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior problems in phenylketonuria. Attempt at a biochemical interpretation based on a personal case and a review of the literature].
    Dalery J; Maillet J; de Villard R
    Encephale; 1983; 9(3):279-90. PubMed ID: 6653487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The biochemic lesions in phenylketonuria].
    Belzecka K
    Postepy Biochem; 1966; 12(3):363-71. PubMed ID: 5333812
    [No Abstract]   [Full Text] [Related]  

  • 10. No evidence for individual blood-brain barrier phenylalanine transport to influence clinical outcome in typical phenylketonuria patients.
    Pietz J; Rupp A; Burgard P; Boesch C; Kreis R
    Ann Neurol; 2002 Sep; 52(3):382-3; author reply 383-4. PubMed ID: 12205657
    [No Abstract]   [Full Text] [Related]  

  • 11. Dosage parameters of a behavioral deficit associated with phenylketonuria in rats.
    Polidora VJ; Cunningham RF; Waisman HA
    J Comp Physiol Psychol; 1966 Jun; 61(3):436-41. PubMed ID: 5949310
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems posed by maternal phenylketonuria].
    Corbeel L
    Arch Fr Pediatr; 1983; 40 Suppl 1():281-2. PubMed ID: 6882148
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain phenylalanine measurement in patients with phenylketonuria: a serious diagnostic method or just reading tea leaves?
    Bik-Multanowski M; Pietrzyk JJ
    Mol Genet Metab; 2007 Jul; 91(3):297-8. PubMed ID: 17482495
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of phenylalanine intake on phenylketonuria.
    BICKEL H; GERRARD J; HICKMANS EM
    Lancet; 1953 Oct; 265(6790):812-3. PubMed ID: 13098090
    [No Abstract]   [Full Text] [Related]  

  • 15. [The pathogenetic problem of phenylpyruvic oligophrenia].
    Cumer Bruno S; Bruno A
    Riv Neurobiol; 1966; 12(4):529-88. PubMed ID: 5994783
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phenylketonuria].
    Niinikoski H; Heikkilä J; Näntö-Salonen K
    Duodecim; 2009; 125(10):1069-75. PubMed ID: 19585905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of cerebral dysfunction in phenylketonuria].
    Valdivieso F; Giménez C; Benavides J; Aragón MC; Mayor F
    Rev Esp Fisiol; 1982; 38 Suppl():189-93. PubMed ID: 7146576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylketonuria; two unusual cases.
    ARMSTRONG MD; CARLISLE JW; LOW NL
    Lancet; 1956 Nov; 271(6949):917-8. PubMed ID: 13368555
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contribution to the study of phenylketonuria].
    Frisone L
    G Psichiatr Neuropatol; 1966; 94(3):637-59. PubMed ID: 5958896
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathogenetic mechanisms in phenylketonuria: disorders affecting the metabolism of neurotransmitters and the antioxidant system].
    Ormazábal A; Artuch R; Vilaseca MA; García-Cazorla A; Campistol J
    Rev Neurol; 2004 Nov 16-30; 39(10):956-61. PubMed ID: 15573314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.